Skip to Main Content

Paper Details

Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.
Cancer Cell
21
2022
Author NameAffiliation
Kathleen E HoulahanStanford Cancer Institute, Stanford University School of Medicine
Jose A SeoaneStanford Cancer Institute, Stanford University School of Medicine, USA Vall d'Hebron Institute of Oncology
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Tari A KingDana-Farber Cancer Institute, Brigham and Women's Hospital
Julie NangiaUSA Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Anna Maria StornioloIndiana University
Christina CurtisStanford Cancer Institute, Stanford University School of Medicine, Stanford University
Kouros OwzarDuke Cancer Institute, Duke University School of Medicine
Kornelia PolyakDana-Farber Cancer Institute
Kornelia PolyakDana-Farber Cancer Institute
Graham A ColditzWashington University School of Medicine
Graham A ColditzWashington University School of Medicine
  • 1 - 13

Datasets

Release 1.2